150 related articles for article (PubMed ID: 15282342)
1. Targets of fibroblast growth factor 1 (FGF-1) and FGF-2 signaling involved in the invasive and tumorigenic behavior of carcinoma cells.
Billottet C; Elkhatib N; Thiery JP; Jouanneau J
Mol Biol Cell; 2004 Oct; 15(10):4725-34. PubMed ID: 15282342
[TBL] [Abstract][Full Text] [Related]
2. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2.
Billottet C; Janji B; Thiery JP; Jouanneau J
Oncogene; 2002 Nov; 21(53):8128-39. PubMed ID: 12444548
[TBL] [Abstract][Full Text] [Related]
3. Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness.
Pai R; Tarnawski AS; Tran T
Mol Biol Cell; 2004 May; 15(5):2156-63. PubMed ID: 15004225
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
5. FGF-1 and FGF-2 regulate the expression of E-cadherin and catenins in pancreatic adenocarcinoma.
El-Hariry I; Pignatelli M; Lemoine NR
Int J Cancer; 2001 Dec; 94(5):652-61. PubMed ID: 11745459
[TBL] [Abstract][Full Text] [Related]
6. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
[TBL] [Abstract][Full Text] [Related]
7. Modulation of several waves of gene expression during FGF-1 induced epithelial-mesenchymal transition of carcinoma cells.
Billottet C; Tuefferd M; Gentien D; Rapinat A; Thiery JP; Broët P; Jouanneau J
J Cell Biochem; 2008 Jun; 104(3):826-39. PubMed ID: 18189245
[TBL] [Abstract][Full Text] [Related]
8. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
Zhang L; Kharbanda S; Hanfelt J; Kern FG
Cancer Res; 1998 Jan; 58(2):352-61. PubMed ID: 9443417
[TBL] [Abstract][Full Text] [Related]
9. Epithelial cell plasticity in development and tumor progression.
Thiery JP; Chopin D
Cancer Metastasis Rev; 1999; 18(1):31-42. PubMed ID: 10505544
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
Fujimoto K; Sheng H; Shao J; Beauchamp RD
Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
[TBL] [Abstract][Full Text] [Related]
11. FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo.
Jouanneau J; Plouet J; Moens G; Thiery JP
Oncogene; 1997 Feb; 14(6):671-6. PubMed ID: 9038374
[TBL] [Abstract][Full Text] [Related]
12. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
Wang X; Weng LP; Yu Q
Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway.
Debiais F; Lefèvre G; Lemonnier J; Le Mée S; Lasmoles F; Mascarelli F; Marie PJ
Exp Cell Res; 2004 Jul; 297(1):235-46. PubMed ID: 15194439
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2, and FGF receptor-1 in human malignant salivary gland tumours.
Myoken Y; Myoken Y; Okamoto T; Sato JD; Kan M; McKeehan WL; Nakahara M; Takada K
J Pathol; 1996 Apr; 178(4):429-36. PubMed ID: 8691322
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation.
Strutz F; Zeisberg M; Hemmerlein B; Sattler B; Hummel K; Becker V; Müller GA
Kidney Int; 2000 Apr; 57(4):1521-38. PubMed ID: 10760088
[TBL] [Abstract][Full Text] [Related]
17. Direct FGF receptor 1 activation through an anti-idiotypic strategy mimicks the biological activity of FGF-2 and inhibits the progression of the bladder carcinoma derived from NBT-II cells.
Malavaud B; Pedron S; Sordello S; Mazerolles C; Billottet C; Thiery JP; Jouanneau J; Plouët J
Oncogene; 2004 Sep; 23(40):6769-78. PubMed ID: 15273729
[TBL] [Abstract][Full Text] [Related]
18. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
19. Essential role of fibroblast growth factor signaling in preadipoctye differentiation.
Patel NG; Kumar S; Eggo MC
J Clin Endocrinol Metab; 2005 Feb; 90(2):1226-32. PubMed ID: 15522930
[TBL] [Abstract][Full Text] [Related]
20. Acidic fibroblast growth factor (FGF-1) and FGF receptor 1 signaling in human Y79 retinoblastoma.
Siffroi-Fernandez S; Cinaroglu A; Fuhrmann-Panfalone V; Normand G; Bugra K; Sahel J; Hicks D
Arch Ophthalmol; 2005 Mar; 123(3):368-76. PubMed ID: 15767480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
